United Kingdom · Question · Written question
UIN 190133
Clinical Trials
Introduced
19 June 2023
Last action
26 June 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
26 June 2023
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the time taken to conduct clinical trial approvals by the Medicines and Healthcare products Regulatory Agency on the UK's life sciences sector
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 June 2023
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the time taken to conduct clinical trial approvals by the Medicines and Healthcare products Regulatory Agency on the UK's life sciences sector
Source: Commons
26 June 2023
Answer
The Medicines and Healthcare products Regulatory Agency (MHRA) is committed to making regulatory decisions in accordance with statutory timeframes. The MHRA has recently undertaken a significant recruitment exercise to bring on board new specialist staff ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-06-19/190133
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1645690
- uk · wq-1645690 · source updated 26 June 2023